XML 34 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
TDCC Consolidated Statements of Income Consolidated Statements of Income - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net sales $ 44,622 $ 56,902 $ 54,968
Cost of sales 39,742 48,338 44,191
Research and development expenses 829 851 857
Selling, general and administrative expenses 1,627 1,675 1,645
Amortization of intangibles 324 336 388
Restructuring and asset related charges - net 528 118 6
Equity in earnings (losses) of nonconsolidated affiliates (119) 268 975
Sundry income (expense) - net (280) 727 (35)
Interest income 229 173 55
Interest expense and amortization of debt discount 746 662 731
Income before income taxes 656 6,090 8,145
Provision (credit) for income taxes (4) 1,450 1,740
Net income (loss) 660 4,640 6,405
Net income attributable to noncontrolling interests 71 58 94
Net income available for The Dow Chemical Company common stockholder 589 4,582 6,311
The Dow Chemical Company      
Net sales 44,622 56,902 54,968
Cost of sales 39,738 48,332 44,187
Research and development expenses 829 851 857
Selling, general and administrative expenses 1,627 1,675 1,645
Amortization of intangibles 324 336 388
Restructuring and asset related charges - net 528 118 6
Equity in earnings (losses) of nonconsolidated affiliates (119) 268 975
Sundry income (expense) - net (327) 714 (79)
Interest income 239 181 56
Interest expense and amortization of debt discount 746 662 731
Income before income taxes 623 6,091 8,106
Provision (credit) for income taxes (4) 1,450 1,738
Net income (loss) 627 4,641 6,368
Net income attributable to noncontrolling interests 71 58 94
Net income available for The Dow Chemical Company common stockholder $ 556 $ 4,583 $ 6,274